Digital ECG maker AliveCor is partnering up with Chinese wearable maker Huami to combine the technologies of each company to deliver a new generation of medical functionality to wearable devices.

“AliveCor's Intelligent, medical grade, heart care platform will be a key component of Huami smart watches and heart trackers going forward. Our new partnership is critical to building these as well as entirely new medical grade services,” said Wang Huang, CEO of Huami.

Read more AliveCor Raises $5.8 Million in New Funds, SEC Filing Reveals

This agreement encompasses the licensing of AliveCor technology and an agreement to work together to bring new devices and services to market. The companies expect that the alliance will deliver entirely new ECG form factors to global markets in 2020, said AliveCor in a press release.

“AliveCor's agreement with Huami achieves our corporate goal of delivering AliveCor's AI driven subscription services and solutions to enterprise customers and consumers worldwide at affordable price points. AliveCor technology allows partners to easily deliver clinically validated, peer-reviewed medical features to their own customers, at scale,” said AliveCor CEO Priya Abani.

‍

‍

Read more Huami and Timex Group Announce Partnership to Develop Innovative Wearables

About Huami

Founded in Hefei, China in 2013, Huami is the largest wearable device company worldwide with over 50 million units sold today and 17.1% global market share. Huami is also the exclusive provider of wearable technology for Xiaomi and maker of the Mi Band. In 2018, Huami shipped 27.5 million units of smart wearable devices. Huami has one of the largest biometric and activity databases in the global smart wearables industry.

About AliveCor

Mountain View, CA-based Mobile ECG maker AliveCor focuses on single- and six-lead smartphone ECGs and AI-based reading interpretations. The company’s FDA-cleared KardiaMobile is the most clinically validated personal ECG solution in the world. KardiaMobile provides instant detection of Atrial Fibrillation, Bradycardia, Tachycardia, and Normal rhythm in an ECG. Kardia is the first AI enabled platform to aid patients and clinicians in the early detection of atrial fibrillation, the most common arrhythmia and one associated with a five times greater risk of stroke. AliveCor was named the No.1 artificial intelligence company in Fast Company's Top 50 Most Innovative Companies.

‍